Chicago, Illinois 4/15/2009 11:58:15 PM
Freshwater Technologies has the water market at it's fingertips
Stocks to Watch: FRESHWATER TECHS INC (OTC BB: FWTC.OB), CAPITAL ONE FINANCIA (NYSE: COF), Xilinx, Inc. (NasdaqGS: XLNX), The Charles Schwab Corporation (NasdaqGS: SCHW), Cell Genesys, Inc. (NasdaqGM: CEGE).
Freshwater Technologies Inc (FRESHWATER TECHS INC(OTC BB: FWTC.OB) is a “green” stock worth watching these days. The company has a proven patented technology that is chemical free,/ environmentally friendly, has applications for heating & cooling, agriculture and fish/shrimp farming and an attractive financial, scenario based on a significant joint venture with the manufacturer and superior returns due to a long term rental strategy. Most importantly, the company has no comparable competition in terms of water activation.
Distributors work on a commission basis and Freshwater maintains a lean corporate structure. Distributors generally are in the type of equipment sales such as boilers and refrigeration units that are a logical user for ELCE water activation.
For a comprehensive coverage please visit:
www.wallstreetstockreview.com
Other Stocks To Watch:
CAPITAL ONE FINANCIA (NYSE: COF)
Capital One Financial Corporation, through its subsidiaries, provides various financial products and services to consumers, small businesses, and commercial clients in the United States.
Xilinx, Inc. (NasdaqGS: XLNX)
Xilinx, Inc. engages in the design, development, and manufacture of programmable logic solutions. It offers advanced integrated circuits in the form of programmable logic devices (PLDs); software design tools to program the PLDs; predefined system functions delivered as intellectual property cores; design services; customer training; and field engineering and technical support solutions.
The Charles Schwab Corporation (NasdaqGS: SCHW)
The Charles Schwab Corporation provides securities brokerage, banking, and related financial services to individual, institutional, and corporate clients.
Cell Genesys, Inc. (NasdaqGM: CEGE)
Cell Genesys, Inc. does not have significant operations. The company is evaluating strategic alternatives, including merger with or acquisition by another company, further restructuring of the company, allocation of its resources towards other biopharmaceutical product areas, sale of the companys assets, and liquidation of the company.
Disclaimer
WallStreetStockReview.com is owned and operated by Iron Consulting.
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering secu rities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b),WallStreetStockReview.com is owned and operated by Iron Consulting. Iron Consulting has received ten thousand dollars Equity Alliance Intl. www.equityallianceir.com for a one month internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Growth stock tips and smallcap newsletter!
(с) 2006 WallStreetStockReview.All Rights Reserved. Disclaimer. Glossary.
E-mail: info@wallstreetstockreview.com
